Lifesaving operations at risk say US surgeons
This article was originally published in Clinica
US surgeons have warned that they will be forced to stop performing accepted lifesaving procedures and instead use only "approved" - but more invasive, dangerous and costly - surgical techniques. At issue is a year-long US Department of Justice/Department of Health & Human Services Inspector General investigation into hospital billings for use of unapproved cardiac devices. The Justice Department issued 125 subpoenas last June, alleging that institutions charged Medicare and Medicaid programmes for these products even though US law forbids reimbursement until the devices are approved.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.